HFD-administered rats exhibited significantly impaired insulin signaling, evidenced by decreased PI3K and Akt phosphorylation, compared with that in the rats in the control group, and the lowest expression of p-PI3K and p-AKT proteins in the hepatic tissue of the NAFLD + CIA rats. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.